About Skin Cancer
LONDON, 15th August, 2019 – Corium Health Ltd, a progressive developer of cosmeceutical, skin cleansing and skin care brands, has commenced it's expansion into Europe with the announcement that its flagship product Microskin™ has launched in Belgium, The Netherlands and Luxembourg.
Corium Health have launched their patented simulated skin brand Microskin™ in the Benelux region of Europe, beginning an exclusive partnership with established cosmeceutical distribution company Beaupharma BV. The partnership will see Beaupharma developing sales channels and introducing partnerships for the Microskin™ brand to assist in expansion across The Netherlands, Belgium and Luxembourg. In the 3 months since launch Beaupharma BV have developed partnerships with the :
AMC hospital group - The Netherlands largest Hospital with a specialist Dermatology division specialising in the treatment of Vitiligo
University of Applied Sciences Utrecht - The Netherlands largest Medical University for the training of Skin Therapists and Dermatologists.
Dutch Burns Foundation - specialises in research into burns (treatment) and for the care and treatment of people with burn injuries and has a database exceeding 1 million people throughout the Benelux region.
Microskin™ is a patented “simulated skin” technology, currently used by people who want to conceal skin conditions such as vitiligo, rosacea, birthmarks, burns, eczema, lupus, keloid scarring, tattoos, and many other skin-related conditions. Unlike traditional cosmetic solutions Microskin™ effectively lasts on the skin for several days, is waterproof, flexible without blocking pores, and will not rub off or transfer onto clothing.
Beaupharma have begun distribution into their territory with Microskin™ products now available across more than 30 specialised skin therapy clinics, Hospitals and Dermatology centres. Each client that undergoes a Microskin™ consultation receives an individualised product kit that can easily be applied at home and on average will see repurchase take place on a quarterly basis.
David Robinson, Managing Director of Corium Health, said “Beaupharma are specialists in this space with more than 20 years experience in cosmeceutical sales and distribution. Their network of partners has already delivered blue chip partnerships for the Microskin™ brand and our agreement with them provides Corium Health with guaranteed revenues over the life of the agreement. The rate of growth we are seeing from this new market is surprising and we are excited about the prospects for Microskin™ as Beaupharma continue to grow the brand throughout the Benelux region”.
About Corium Health Ltd
Corium Health is a progressive developer of cosmeceutical, skin cleansing and skin care brands. The company was established to expand the benefits offered by Microskin™ which is a patented simulated skin technology. By utilising the IP and Technology owned by Corium Health, we provide market leading products into the constantly growing "personal care" marketplace that redefine and set a new benchmark in each of their specialised categories. For more information, please visit www.microskin.com or www.coriumhealth.com
